Acacia Diversified Holdings, Inc. (OTCPK:ACCA) entered into an agreement to acquire substantially all of the assets of Canna-Cures R&D, LLC for $0.01 million in stock on June 29, 2015. Under the terms of the agreement, Acacia Diversified Holdings will issue 0.012 million shares as consideration. In related transactions, Acacia Diversified also agreed to acquire JR Cannabis Industries and MariJ Agricultural. The assets and businesses of Canna-Cures will be absorbed into new wholly-owned operating subsidiaries of Acacia, with the main impetus being on its new MariJ Pharmaceuticals, Inc. At the Closing of the acquisition, Steve Sample resigned his posts as Acacia's Chief Execuitve Officer, President, and Chairman of the Board in favor of Acacia's Executive, President and Chairman, Richard K. Pertile. Dan L. Rigdon and V. Weldon Hewitt shall resign as directors of Acacia. Majority of the employees of Canna-Cures were retained. The deal is subject to consummation of due diligence investigation, execution of employment and non-competition agreement and has been approved by shareholders of Acacia. Howard P. Ross, B.C.S acted as legal advisor for Canna-Cures.

Acacia Diversified Holdings, Inc. (OTCPK:ACCA) completed the acquisition of substantially all of the assets of Canna-Cures R&D, LLC on January 4, 2016.